Will This ETF Beat the Market Over the Next 12 Months?
2024 was another banner year for the US stock market,…
Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
---|---|---|---|---|---|---|
Revenue | $2.9B | $3.2B | $3.5B | $3.6B | $3.8B | |
Revenue Growth (YoY) | 6.6% | 10.52% | 8.23% | 4.49% | 5.4% | |
Cost of Revenues | $987.6M | $1.1B | $1.3B | $1.4B | $1.5B | |
Gross Profit | $1.9B | $2.1B | $2.2B | $2.2B | $2.3B | |
Gross Profit Margin | 65.87% | 64.58% | 63.34% | 61.74% | 60.36% | |
R&D Expenses | $261.4M | $269.3M | $335.4M | $391.4M | $406M | |
Selling, General & Admin | $947.5M | $966.7M | $919M | $984.1M | $1.1B | |
Other Inc / (Exp) | -$30.5M | -$45.6M | -$22.3M | -$45.2M | -$78.4M | |
Operating Expenses | $1.3B | $1.4B | $1.4B | $1.5B | $1.6B | |
Operating Income | $578M | $701.7M | $807.2M | $711M | $703.4M | |
Net Interest Expenses | $15M | $40M | $56.7M | $7.8M | -- | |
EBT. Incl. Unusual Items | $532.5M | $616.1M | $728.2M | $658M | $652.5M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $53.4M | $45.9M | $62.6M | $126.7M | $106.4M | |
Net Income to Company | $478M | $557.1M | $651.6M | $523.7M | $547.6M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $478M | $557.1M | $651.6M | $523.7M | $547.6M | |
Basic EPS (Cont. Ops) | $2.94 | $3.43 | $4.01 | $3.29 | $3.59 | |
Diluted EPS (Cont. Ops) | $2.90 | $3.37 | $3.93 | $3.26 | $3.52 | |
Weighted Average Basic Share | $162.7M | $162.5M | $162.7M | $159.1M | $152.5M | |
Weighted Average Diluted Share | $164.6M | $165.2M | $165.8M | $160.5M | $155.4M | |
EBITDA | $1B | $1.2B | $1.4B | $1.3B | $1.2B | |
EBIT | $581.8M | $685.2M | $800.6M | $669.1M | $670.2M | |
Revenue (Reported) | $2.9B | $3.2B | $3.5B | $3.6B | $3.8B | |
Operating Income (Reported) | $578M | $701.7M | $807.2M | $711M | $703.4M | |
Operating Income (Adjusted) | $581.8M | $685.2M | $800.6M | $669.1M | $670.2M |
Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
---|---|---|---|---|---|---|
Revenue | $792.8M | $860.3M | $881.9M | $965.5M | $1B | |
Revenue Growth (YoY) | 11.68% | 8.51% | 2.51% | 9.48% | 4.06% | |
Cost of Revenues | $283.4M | $316.9M | $346.5M | $383.1M | $408.8M | |
Gross Profit | $509.4M | $543.5M | $535.4M | $582.4M | $595.9M | |
Gross Profit Margin | 64.25% | 63.17% | 60.72% | 60.32% | 59.31% | |
R&D Expenses | $66.8M | $82.9M | $94M | $105.9M | $120.3M | |
Selling, General & Admin | $231.1M | $220.6M | $239.9M | $262.7M | $275.5M | |
Other Inc / (Exp) | -$3.2M | $1.8M | -$4.1M | -$8M | -$100.2M | |
Operating Expenses | $327.2M | $336.3M | $371.2M | $401.5M | $438.2M | |
Operating Income | $182.2M | $207.1M | $164.3M | $180.9M | $157.7M | |
Net Interest Expenses | $11M | $15.3M | $2M | -- | -- | |
EBT. Incl. Unusual Items | $168M | $193.6M | $158.2M | $179.4M | $73.8M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $8.8M | $13.6M | $34.5M | $20.3M | $15.9M | |
Net Income to Company | $158.6M | $178.9M | $123.7M | $160.5M | $57.9M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $158.6M | $178.9M | $123.7M | $160.5M | $57.9M | |
Basic EPS (Cont. Ops) | $0.97 | $1.10 | $0.78 | $1.06 | $0.38 | |
Diluted EPS (Cont. Ops) | $0.95 | $1.08 | $0.78 | $1.04 | $0.38 | |
Weighted Average Basic Share | $162.8M | $162.8M | $158.7M | $151.4M | $151.4M | |
Weighted Average Diluted Share | $166.5M | $166.3M | $159.1M | $155M | $153.2M | |
EBITDA | $304.2M | $351.5M | $310.8M | $331.4M | $244.3M | |
EBIT | $185.3M | $211.8M | $159.8M | $182.9M | $78.6M | |
Revenue (Reported) | $792.8M | $860.3M | $881.9M | $965.5M | $1B | |
Operating Income (Reported) | $182.2M | $207.1M | $164.3M | $180.9M | $157.7M | |
Operating Income (Adjusted) | $185.3M | $211.8M | $159.8M | $182.9M | $78.6M |
Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
---|---|---|---|---|---|---|
Revenue | $3.1B | $3.4B | $3.6B | $3.7B | $4B | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $1.1B | $1.2B | $1.4B | $1.5B | $1.6B | |
Gross Profit | $2B | $2.2B | $2.2B | $2.3B | $2.4B | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | $271M | $309.4M | $379.2M | $402.2M | $459.8M | |
Selling, General & Admin | $946.5M | $955.4M | $971.1M | $1B | $1.1B | |
Other Inc / (Exp) | -$41.4M | -$30.9M | -$56.9M | -$77.9M | -$110.9M | |
Operating Expenses | $1.3B | $1.4B | $1.5B | $1.6B | $1.7B | |
Operating Income | $692.1M | $760M | $752.5M | $689.8M | $661.8M | |
Net Interest Expenses | $34.2M | $52.9M | $25.1M | -- | -- | |
EBT. Incl. Unusual Items | $616.6M | $676.2M | $670.6M | $624.7M | $625.1M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $52.4M | $47.7M | $106.1M | $110.9M | $99M | |
Net Income to Company | $562.8M | $604.5M | $555.4M | $515.2M | $526.2M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $562.8M | $604.5M | $555.4M | $515.2M | $526.2M | |
Basic EPS (Cont. Ops) | $3.47 | $3.71 | $3.46 | $3.35 | $3.47 | |
Diluted EPS (Cont. Ops) | $3.41 | $3.64 | $3.42 | $3.32 | $3.38 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | $1.2B | $1.3B | $1.3B | $1.2B | $1.3B | |
EBIT | $685M | $747.6M | $697.5M | $637.2M | $652.4M | |
Revenue (Reported) | $3.1B | $3.4B | $3.6B | $3.7B | $4B | |
Operating Income (Reported) | $692.1M | $760M | $752.5M | $689.8M | $661.8M | |
Operating Income (Adjusted) | $685M | $747.6M | $697.5M | $637.2M | $652.4M |
Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
---|---|---|---|---|---|---|
Revenue | $2.4B | $2.6B | $2.7B | $2.8B | $3B | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $828.8M | $943.6M | $1B | $1.1B | $1.2B | |
Gross Profit | $1.5B | $1.6B | $1.7B | $1.7B | $1.8B | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | $202.1M | $242.2M | $286.1M | $296.8M | $350.6M | |
Selling, General & Admin | $688.8M | $677.6M | $729.8M | $784.6M | $817.9M | |
Other Inc / (Exp) | -$19.8M | -$5.1M | -$39.7M | -$72.4M | -$104.9M | |
Operating Expenses | $987.2M | $1B | $1.1B | $1.2B | $1.3B | |
Operating Income | $535.8M | $594.2M | $539.5M | $518.3M | $476.7M | |
Net Interest Expenses | $28.9M | $41.8M | $10.2M | -- | -- | |
EBT. Incl. Unusual Items | $487.1M | $547.2M | $489.6M | $456.3M | $428.9M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $41.8M | $43.6M | $87.1M | $71.3M | $63.9M | |
Net Income to Company | $443.7M | $491.1M | $394.9M | $386.5M | $365M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $443.7M | $491.1M | $394.9M | $386.5M | $365M | |
Basic EPS (Cont. Ops) | $2.73 | $3.01 | $2.47 | $2.53 | $2.40 | |
Diluted EPS (Cont. Ops) | $2.68 | $2.96 | $2.45 | $2.50 | $2.35 | |
Weighted Average Basic Share | $487.2M | $488.9M | $479.2M | $459.1M | $455.3M | |
Weighted Average Diluted Share | $495M | $498.3M | $484.4M | $464.6M | $464.3M | |
EBITDA | $889.6M | $1B | $942.4M | $887.6M | $925.8M | |
EBIT | $538.9M | $601.3M | $498.2M | $464.4M | $445.4M | |
Revenue (Reported) | $2.4B | $2.6B | $2.7B | $2.8B | $3B | |
Operating Income (Reported) | $535.8M | $594.2M | $539.5M | $518.3M | $476.7M | |
Operating Income (Adjusted) | $538.9M | $601.3M | $498.2M | $464.4M | $445.4M |
Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $393.7M | $352.9M | $536.7M | $542.3M | $489.5M | |
Short Term Investments | $1.1B | $745.2M | $541.5M | $563M | $375M | |
Accounts Receivable, Net | $396.2M | $473.5M | $502M | $490.2M | $516.2M | |
Inventory | -- | -- | -- | -- | -- | |
Prepaid Expenses | $80.1M | $96.4M | $106.1M | $132.7M | $129.8M | |
Other Current Assets | $17.6M | $20.5M | $16.7M | $15M | $42M | |
Total Current Assets | $2.2B | $1.9B | $1.9B | $2B | $1.8B | |
Property Plant And Equipment | $1.9B | $2.3B | $2.5B | $2.4B | $2.7B | |
Long-Term Investments | $835.4M | $1.4B | $1.1B | $320.5M | $1.4B | |
Goodwill | $1.6B | $1.7B | $2.2B | $2.8B | $2.9B | |
Other Intangibles | $179.4M | $234.7M | $313.2M | $441.7M | $536.1M | |
Other Long-Term Assets | $173.1M | $147.6M | $142.3M | $116.5M | $124.3M | |
Total Assets | $7B | $7.8B | $8.1B | $8.3B | $9.9B | |
Accounts Payable | $138.9M | $118.5M | $109.9M | $145.4M | $146.9M | |
Accrued Expenses | $257.7M | $288M | $298.4M | $259.8M | $243.9M | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | $139.5M | $154.8M | $175.7M | $196.1M | $222.9M | |
Other Current Liabilities | $14.8M | $34M | $13M | $5.2M | $6.4M | |
Total Current Liabilities | $693.3M | $758.2M | $790.3M | $818.9M | $836M | |
Long-Term Debt | $1.8B | $1.9B | $2B | $2.3B | $3.5B | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $3.3B | $3.5B | $3.6B | $3.9B | $5.3B | |
Common Stock | $1.6M | $1.6M | $1.6M | $1.6M | $1.5M | |
Other Common Equity Adj | -$45.1M | -$20.2M | -$69.1M | -$140.3M | -$95.3M | |
Common Equity | $3.7B | $4.3B | $4.5B | $4.4B | $4.6B | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $3.7B | $4.3B | $4.5B | $4.4B | $4.6B | |
Total Liabilities and Equity | $7B | $7.8B | $8.1B | $8.3B | $9.9B | |
Cash and Short Terms | $1.5B | $1.1B | $1.1B | $1.1B | $864.4M | |
Total Debt | $1.8B | $1.9B | $2B | $2.3B | $3.5B |
Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $742.5M | $1.3B | $457.8M | $459.9M | $569.7M | |
Short Term Investments | $701.5M | $652.7M | $406.3M | $479.4M | $1.1B | |
Accounts Receivable, Net | $471.1M | $479.3M | $445.8M | $514.4M | $492.5M | |
Inventory | -- | -- | -- | -- | -- | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | $168.8M | $184.5M | $209.4M | $214.7M | $238.7M | |
Total Current Assets | $2.2B | $2.8B | $1.7B | $1.9B | $2.6B | |
Property Plant And Equipment | $2.1B | $2.4B | $2.3B | $2.7B | $3B | |
Long-Term Investments | $1.1B | $835.1M | $488.5M | $1.2B | $279.4M | |
Goodwill | $1.6B | $1.7B | $2.8B | $2.8B | $3.2B | |
Other Intangibles | $184.5M | $203.6M | $455M | $465.2M | $586.2M | |
Other Long-Term Assets | $151.3M | $133.8M | $105.3M | $122.4M | $149.8M | |
Total Assets | $7.5B | $8.1B | $8.1B | $9.6B | $10.2B | |
Accounts Payable | $114.9M | $98.3M | $119.1M | $144.5M | $106.6M | |
Accrued Expenses | $369.8M | $376M | $329.2M | $329.4M | $288.6M | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | $1.1B | |
Current Portion Of Capital Lease Obligations | $136.3M | $164.6M | $187.8M | $205.1M | $251.6M | |
Other Current Liabilities | $7.2M | $9.2M | $7.2M | $7.2M | $48.8M | |
Total Current Liabilities | $717.1M | $731.4M | $753M | $810.5M | $2B | |
Long-Term Debt | $1.9B | $2B | $2.3B | $3.5B | $2.4B | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $3.4B | $3.5B | $3.9B | $5.3B | $5.4B | |
Common Stock | $1.6M | $1.6M | $1.6M | $1.6M | $1.5M | |
Other Common Equity Adj | -$45.9M | -$53.7M | -$28.5M | -$137.5M | -$100.4M | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $4.1B | $4.6B | $4.2B | $4.3B | $4.8B | |
Total Liabilities and Equity | $7.5B | $8.1B | $8.1B | $9.6B | $10.2B | |
Cash and Short Terms | $1.4B | $1.9B | $864.1M | $939.3M | $1.7B | |
Total Debt | $1.9B | $2B | $2.3B | $3.5B | $3.5B |
Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $478M | $557.1M | $651.6M | $523.7M | $547.6M | |
Depreciation & Amoritzation | $440.7M | $478.4M | $550.6M | $592.8M | $570.8M | |
Stock-Based Compensation | $187.1M | $197.4M | $202.8M | $217.2M | $328.5M | |
Change in Accounts Receivable | -$64.5M | -$90.4M | -$24.1M | -$21.2M | -$49.2M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $1.1B | $1.2B | $1.4B | $1.3B | $1.3B | |
Capital Expenditures | $562.1M | $731.9M | $545.2M | $458.3M | $730M | |
Cash Acquisitions | -$201.3M | -$128M | -$598.8M | -$872.1M | -$106.2M | |
Cash From Investing | -$1.7B | -$1B | -$646.9M | -$622.3M | -$1.8B | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $1.1B | -- | -- | $125M | $1.3B | |
Long-Term Debt Repaid | -$690M | -- | -- | -$125M | -$90M | |
Repurchase of Common Stock | -$334.5M | -$193.6M | -$522.3M | -$608M | -$654M | |
Other Financing Activities | -$389M | -$89.8M | -$99.4M | -$82.6M | -$303.1M | |
Cash From Financing | -$35.7M | -$223.6M | -$562M | -$634.2M | $443.4M | |
Beginning Cash (CF) | $1B | $394.1M | $353.5M | $537.8M | $543M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$645.3M | -$51.6M | $195.7M | $18.2M | -$56.4M | |
Ending Cash (CF) | $394.1M | $353.5M | $537.8M | $543M | $490.5M | |
Levered Free Cash Flow | $496.2M | $483.1M | $859.3M | $816.4M | $618.4M |
Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $158.6M | $178.9M | $123.7M | $160.5M | $57.9M | |
Depreciation & Amoritzation | $118.9M | $139.7M | $151M | $148.6M | $165.7M | |
Stock-Based Compensation | $50.2M | $49M | $50.7M | $87M | $102.6M | |
Change in Accounts Receivable | $20.1M | -$10.8M | $30.8M | -$23.5M | $11.3M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $402M | $389.7M | $369.3M | $359.4M | $392.5M | |
Capital Expenditures | $228.8M | $116.2M | $98M | $197.6M | $185.1M | |
Cash Acquisitions | -- | -- | $8K | $155K | -- | |
Cash From Investing | -$224.7M | $393M | -$95.5M | -$1.2B | -$116.2M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | $1.2B | -- | |
Long-Term Debt Repaid | -- | -- | -$75M | -$20M | -- | |
Repurchase of Common Stock | -$13.2M | -$96.8M | -$162.6M | -$113.2M | -$165.8M | |
Other Financing Activities | -$13.4M | -$12.1M | -$8.7M | -$248M | -$16M | |
Cash From Financing | -$10.6M | -$93.2M | -$229.5M | $974.6M | -$162.4M | |
Beginning Cash (CF) | $572.9M | $581.7M | $427.5M | $299.4M | $449.3M | |
Foreign Exchange Rate Adjustment | $4.4M | -$5.1M | -$12M | -$7M | $9.5M | |
Additions / Reductions | $166.7M | $689.6M | $44.3M | $169.9M | $113.9M | |
Ending Cash (CF) | $744M | $1.3B | $459.8M | $462.3M | $572.8M | |
Levered Free Cash Flow | $173.2M | $273.5M | $271.3M | $161.8M | $207.4M |
Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $562.8M | $604.5M | $555.4M | $515.2M | $526.2M | |
Depreciation & Amoritzation | $466.5M | $536.6M | $585.9M | $571.7M | $628.1M | |
Stock-Based Compensation | $193.8M | $204.3M | $207.8M | $294.7M | $386.5M | |
Change in Accounts Receivable | -$111.8M | -$20.2M | $18M | -$94.3M | $25.2M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $1.2B | $1.3B | $1.3B | $1.3B | $1.6B | |
Capital Expenditures | $698.1M | $603M | $457.2M | $706.9M | $656.3M | |
Cash Acquisitions | -$43.8M | -$143.7M | -$1.5B | -$106.2M | -$434.1M | |
Cash From Investing | -$1B | -$420.9M | -$1.4B | -$1.6B | -$870.3M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | $125M | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -$163.8M | -$323.8M | -$701.3M | -$776.9M | -$474M | |
Other Financing Activities | -$91.4M | -$101M | -$82.9M | -$298.5M | -$182.7M | |
Cash From Financing | -$195.5M | -$363.9M | -$725.4M | $322.2M | -$595.6M | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$4.3M | $524M | -$777M | -$4.1M | $98.7M | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | $508M | $705.8M | $862.9M | $593.8M | $908.3M |
Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $443.7M | $491.1M | $394.9M | $386.5M | $365M | |
Depreciation & Amoritzation | $350.7M | $408.9M | $444.2M | $423.1M | $480.5M | |
Stock-Based Compensation | $146.9M | $153.8M | $158.8M | $236.3M | $294.3M | |
Change in Accounts Receivable | -$85.4M | -$15.2M | $26.8M | -$46.3M | $28.1M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $923.9M | $1B | $933.2M | $959.2M | $1.2B | |
Capital Expenditures | $564.4M | $435.5M | $347.5M | $596.2M | $522.4M | |
Cash Acquisitions | $106K | -$15.6M | -$872.1M | -$106.2M | -$434.1M | |
Cash From Investing | -$425M | $197.1M | -$527.7M | -$1.5B | -$554.5M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | $125M | $1.3B | -- | |
Long-Term Debt Repaid | -- | -- | -$125M | -$90M | -- | |
Repurchase of Common Stock | -$121.1M | -$251.3M | -$430.3M | -$599.2M | -$419.1M | |
Other Financing Activities | -$77.3M | -$88.5M | -$71.9M | -$287.8M | -$167.4M | |
Cash From Financing | -$152.6M | -$292.8M | -$456.2M | $500.2M | -$538.8M | |
Beginning Cash (CF) | $1.4B | $1.4B | $1.3B | $1.1B | $1.4B | |
Foreign Exchange Rate Adjustment | $3.5M | -$9.2M | -$27.2M | -$7.7M | $188K | |
Additions / Reductions | $346.3M | $921.9M | -$50.7M | -$73M | $82.1M | |
Ending Cash (CF) | $1.7B | $2.3B | $1.3B | $1.1B | $1.5B | |
Levered Free Cash Flow | $359.5M | $582.1M | $585.7M | $363.1M | $653M |
Signup to receive the latest stock alerts
2024 was another banner year for the US stock market,…
Carlos Slim made a splash in a surprising sector last…
There is a lot of humdrum in the market about…
Market Cap: $3.7T
P/E Ratio: 40x
Market Cap: $3.4T
P/E Ratio: 116x
Market Cap: $3.1T
P/E Ratio: 35x
Bright Minds Biosciences [DRUG] is down 4.28% over the past day.
Banco Macro SA [BMA] is up 0.88% over the past day.
Agrify [AGFY] is down 5.86% over the past day.